Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zambelli

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Studies in Health Technology and Informatics|May 27, 2021
i2b2 to Optimize Patients EnrollmentMauro Bucalo, Matteo Gabetta, Lorenzo Chiudinelli, et al.
BMC Cancer|August 25, 2005
Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant gliomaAlberto Zambelli, Daniele Lilleri, Fausto Baldanti, et al.
Studies in Health Technology and Informatics|September 7, 2011
The ONCO-I2b2 project: integrating biobank information and clinical data to support translational research in oncologyDaniele Segagni, Valentina Tibollo, Arianna Dagliati, et al.
Lung Cancer (Amsterdam, Netherlands)|December 8, 2007
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancyAlberto Zambelli, Gian Antonio Da Prada, Vittorio Fregoni, et al.
Plos One|January 12, 2017
Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast CancerFrancesca Vitali, Laurie D Cohen, Andrea Demartini, et al.
Experimental and Therapeutic Medicine|February 15, 2013
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapyChiara Ghimenti, Maurizia Mello-Grand, Enrico Grosso, et al.
Plos One|September 16, 2016
A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast CancerFrancesca Vitali, Laurie D Cohen, Andrea Demartini, et al.
Cancers|April 14, 2025
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic ResponsesJacopo Canzian, Fabio Conforti, Flavia Jacobs, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Clinical and research data integration: the i2b2-FSM experienceDaniele Segagni, Valentina Tibollo, Arianna Dagliati, et al.
Critical Reviews in Oncology/Hematology|October 12, 2024
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysisSilvia Belloni, Paola Tiberio, Rita De Sanctis, et al.
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Studies in Health Technology and Informatics|May 27, 2021
i2b2 to Optimize Patients EnrollmentMauro Bucalo, Matteo Gabetta, Lorenzo Chiudinelli, et al.
BMC Cancer|August 25, 2005
Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant gliomaAlberto Zambelli, Daniele Lilleri, Fausto Baldanti, et al.
Studies in Health Technology and Informatics|September 7, 2011
The ONCO-I2b2 project: integrating biobank information and clinical data to support translational research in oncologyDaniele Segagni, Valentina Tibollo, Arianna Dagliati, et al.
Lung Cancer (Amsterdam, Netherlands)|December 8, 2007
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancyAlberto Zambelli, Gian Antonio Da Prada, Vittorio Fregoni, et al.
Plos One|January 12, 2017
Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast CancerFrancesca Vitali, Laurie D Cohen, Andrea Demartini, et al.
Experimental and Therapeutic Medicine|February 15, 2013
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapyChiara Ghimenti, Maurizia Mello-Grand, Enrico Grosso, et al.
Plos One|September 16, 2016
A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast CancerFrancesca Vitali, Laurie D Cohen, Andrea Demartini, et al.
Cancers|April 14, 2025
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic ResponsesJacopo Canzian, Fabio Conforti, Flavia Jacobs, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Clinical and research data integration: the i2b2-FSM experienceDaniele Segagni, Valentina Tibollo, Arianna Dagliati, et al.
Critical Reviews in Oncology/Hematology|October 12, 2024
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysisSilvia Belloni, Paola Tiberio, Rita De Sanctis, et al.
Pageof 17